Louis J. Arcudi III, M.B.A., MBA is the CEO, Pres & Director at Millendo Therapeutics.
As the CEO y Pres & Director of Millendo Therapeutics, the total compensation of Mr MBA at Millendo Therapeutics is $495,792. There are 4 executives at Millendo Therapeutics getting paid more, with Julia Owens having the highest compensation of $2,381,880.
Mr MBA is 59, he's been the CEO y Pres & Director of Millendo Therapeutics since . There are 2 older and 9 younger executives at Millendo Therapeutics. The oldest executive at Millendo Therapeutics, Inc. is John Howe, 77, who is the Independent Director.
Iii's mailing address filed with the SEC is C/O MILLENDO THERAPEUTICS, INC., 110 MILLER AVENUE, SUITE 100, ANN ARBOR, MI, 48104.
Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.
Millendo Therapeutics executives and other stock owners filed with the SEC include: